Seiichi Villalona, Carlos Chavez Perez, E. Paul Wileyto, Samuel Takvorian, Peter Gabriel, Abigail Doucette, Daniel Blumenthal, Robert Schnoll Predictive Value of Individual Behavioral Risk Factors for New Mood-Related Psychiatric Disorder After Diagnosis of Cancer , Psycho-Oncology: 2024
Gabriel Aleixo, Tej Patel, Julianne Ani, Will J. Ferrell, Efrat Dotan, Samuel U. Takvorian, Grant R. Williams, Ravi B. Parikh, Ramy Sedhom “Start low, go slow,” a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis , Journal of Geriatric Oncology: 2024
Schnoll R, Bekelman JE, Blumenthal D, Asch DA, Buttenheim AM, Chaiyachati KH, Domchek SM, Fayanju OM, Gabriel P, Jenssen BP, Leone FT, McCarthy AM, Nathanson KL, Parikh RB, Rendle KA, Shelton RC, Shulman LN, Takvorian SU, Ware S, Wileyto EP, & Beidas RS Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control , Journal of Clinical and Translational Science, 8(1): 2024
J. Wainwright, H. Toneff, J. Kalman, M. Mengesha, A. Strazinsky, W. Song, S. Beucker, E.P. Wileyto, C. Johnston, C. Cambareri, D. Yarosh, A. Blauch, D. Pucci, L.A. Jacobs, J.E. Bekelman, S.E. Kimmel, L.N. Shulman, S. Takvorian, K. Rendle Acceptability and Feasibility of Integrating A Chatbot into Routine Lung Cancer Care: Patient and Clinician Perspectives , Journal of Thoracic Oncology, International Association for the Study of Lung Cancer, 19(10): 2024
Montgomery A, White J, Blumenthal D, Mengesha M, O’Brien C, Ragusano D, Beidas RS, Schnoll R, Bekelman JE, Parikh RB, Takvorian SU, & Rendle KA Patient and clinician perspectives on the timing of serious illness conversations in oncology , ASCO Quality Care Symposium, San Francisco, CA: 2024
Miles Hsu, Xinhe Shan, Rebecca Zhang, Eva Berlin, Arun Goel, Manuj Agarwal, Yu-Ning Wong, John P. Christodouleas, David J. Vaughn, Vivek Narayan, Samuel U. Takvorian, Neha Vapiwala, Austin R. Pantel, Naomi B. Haas Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on (18)F-DCFPyL PET/CT , Clinical Genitourinary Cancer, 22(4): 2024
Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer , Eur Urol Oncol: 2024
Erin Welch, Marie A. Guerraty, Biniyam G. Demissei, Naomi Haas, Samuel Takvorian, Ravi B. Parikh, David J. Vaughn, Daniel Pryma, David A. Mankoff, Bonnie Ky, Vivek Narayan Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy , Clinical Genitourinary Cancer, 22(4): 2024
Takvorian SU, Gabriel P, Wileyto EP, Blumenthal D, Tejada S, Clifton ABW, Asch DA, Buttenheim AM, Rendle KA, Shelton RC, Chaiyachati KH, Fayanju OM, Ware S, Schuchter LM, Kumar P, Salam T, Lieberman A, Ragusano D, Bauer AM, Scott CA, Shulman LN, Schnoll R, Beidas RS, Bekelman JE, Parikh RB. Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial , JAMA Network Open: 2024
William L. Schpero (co-first), Samuel U. Takvorian (co-first), Daniel Blickstein, Afrah Shafquat, Jingshu Liu, Arnaub K. Chatterjee, Elizabeth B. Lamont, Paula Chatterjee Association Between State Medicaid Policies and Accrual of Black or Hispanic Patients to Cancer Clinical Trials , Journal of Clinical Oncology: 2024
